Search
Paclitaxel Treatment Options in United Kingdom
A collection of 293 research studies where Paclitaxel is the interventional treatment. These studies are located in the United Kingdom . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.
25 - 36 of 293
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruiting
This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer.
This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/06/2025
Locations: Alaska Women's Cancer Care, Anchorage, Alaska +114 locations
Alaska Women's Cancer Care, Anchorage, Alaska
Yale University School of Medicine, New Haven, Connecticut
Sylvester Comprehensive Cancer Center at Lennar, Coral Gables, Florida
Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida
Florida Cancer Specialists, Lake Mary, Florida
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida
Sylvester Cancer Center, Miami, Florida
Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida
Community MD Anderson Cancer Center- East, Indianapolis, Indiana
Community MD Anderson Cancer Center- South, Indianapolis, Indiana
Community Health Network - MD Anderson, Indianapolis, Indiana
St. Elizabeth Medical Center, Edgewood, Kentucky
Washington University School of Medicine Obstetrics and Gynecology, Saint Louis, Missouri
Valley Health System, Paramus, New Jersey
Holy Name, Teaneck, New Jersey
NHPP Imbert, Bay Shore, New York
Northwell Health, LLC PRIME, Lake Success, New York
Perlmutter Cancer Center at NYU Langone Hospital- Long Island, Mineola, New York
NYU Langone Health, New York, New York
NHPP LHH, New York, New York
Duke Women's Cancer Care- Raleigh, Durham, North Carolina
Duke Cancer Center, Durham, North Carolina
Ohio State University Wexner Medical Center, Hilliard, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
Medical University of South Carolina (MUSC), Charleston, South Carolina
Sanford Cancer Center Gynecologic Oncology, Sioux Falls, South Dakota
Texas Oncology-Bedford, Bedford, Texas
Houston Area Locations- Woodlands, Conroe, Texas
Texas Oncology-Presbyterian Cancer Center Dallas, Dallas, Texas
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas
Texas Oncology Paris, Fort Worth, Texas
Houston Methodist Hospital, Houston, Texas
University of Texas - MD Anderson, Houston, Texas
Houston Area Locations- Sugar Land, Houston, Texas
Houston Area Locations- West Houston, Houston, Texas
Houston Area Locations- League City, League City, Texas
GenesisCare St Andrews Hospital, Adelaide, Not set
GenesisCare North Shore (Oncology), St Leonards, Not set
McGill University Health Centre/Glen Site / Royal Victoria Hospital, Montreal, Not set
University Health Network - Princess Margaret Cancer Centre, Toronto, Not set
Beijing Cancer Hospital, Beijing, Not set
Chongqing Cancer Hospital, Chongqing, Not set
Fujian Provincial Cancer Hospital, Fuzhou, Not set
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Shandong Cancer Hospital, Jinan, Not set
Qilu Hospital of Shandong University, Jinan, Not set
Guangxi Medical University Cancer Hospital, Nanning, Not set
Fudan University Shanghai Cancer Center, Shanghai, Not set
National Cheng Kung University Hospital, Tainan, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Hubei Cancer Hospital, Wuhan, Not set
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Not set
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set
Vseobecna fakultni nemocnice v Praze, Praha 2, Not set
Fakultni nemocnice v Motole, Praha 5, Not set
Fakultni nemocnice Bulovka, Praha, Not set
Centre Francois Baclesse, Caen Cedex 05, Not set
Centre Georges François Leclerc, Dijon cedex, Not set
Centre Leon Berard, Lyon, Not set
Institut Paoli Calmettes, Marseille cedex, Not set
Institut du Cancer de Montpellier, Montpellier, Not set
Hôpital Privé du Confluent, Nantes cedex 2, Not set
Groupe Hospitalier Diaconesses - Hôpital De La Croix Saint Simon, Paris cedex 12, Not set
CARIO - Centre Armoricain de Radiothérapie, Imagerie médicale et Oncologie, Plérin, Not set
Institut Curie, Saint Cloud, Not set
ICL Alexis Vautrin, Vandoeuvre les Nancy, Not set
Universitaetsklinikum Mannheim, Mannheim, Not set
IRCCS Centro di Riferimento Oncologico, Aviano, Not set
Azienda Ospedaliera Per Lemergenza Cannizzaro, Catania, Not set
Azienda Ospedaliera Universitaria Careggi, Firenze, Not set
Humanitas San Pio X, Milano, Not set
IEO Istituto Europeo di Oncologia, Milano, Not set
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Not set
Istituto Clinico Humanitas, Rozzano, Not set
Ospedale Mauriziano Umberto I, Torino, Not set
National Cancer Center Hospital, Chuo-ku, Not set
NHO Kyushu Cancer Center, Fukuoka-shi, Not set
Saitama Medical University International Medical Center, Hidaka-shi, Not set
National Cancer Center Hospital East, Kashiwa-shi, Not set
Cancer Institute Hospital of JFCR, Koto-ku, Not set
Jikei University Hospital, Minato-ku, Not set
Shizuoka Cancer Center, Nagaizumi-cho, Not set
Aichi Cancer Center Hospital, Nagoya-shi, Not set
Niigata Cancer Center Hospital, Niigata-shi, Not set
Osaka International Cancer Institute, Osaka-shi, Not set
Hokkaido University Hospital, Sapporo-shi, Not set
Iwate Medical University Hospital, Shiwa-gun, Not set
National Cancer Center, Goyang-si, Not set
CHA Bundang Medical Center, CHA University, Seongnam-si, Not set
National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
Mazowiecki Szpital Wojewodzki w Siedlcach Sp z o o, Siedlce, Not set
Hospital Professor Doutor Fernando Fonseca, E.P.E., Amadora, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Universitario Ciudad de Jaen, Jaén, Not set
Hospital Universitario Clinico San Carlos, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Clinica Universidad de Navarra (MAD), Pamplona, Not set
Clinica Universidad de Navarra, Pamplona, Not set
Hospital Clínico Universitario Valencia, Valencia, Not set
Taichung Veterans General Hospital, Taichung, Not set
Taipei Veterans General Hospital, Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Not set
Chang Gung Memorial Hospital,Linkou, Taoyuan City, Not set
Royal United Hospital, Bath, Not set
Conditions: Solid Cancer
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
Recruiting
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1L treatment in participants with mNSCLC in PD-L1 \< 50%.
The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1L treatment in participants with mNSCLC in PD-L1 \< 50%. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/06/2025
Locations: Research Site, Prescott, Arizona +297 locations
Research Site, Prescott, Arizona
Research Site, Hot Springs National Park, Arkansas
Research Site, Springdale, Arkansas
Research Site, Long Beach, California
Research Site, Palo Alto, California
Research Site, Lone Tree, Colorado
Research Site, Newark, Delaware
Research Site, Fort Myers, Florida
Research Site, Gainesville, Florida
Research Site, Orlando, Florida
Research Site, Saint Petersburg, Florida
Research Site, Tallahassee, Florida
Research Site, West Palm Beach, Florida
Research Site, Fort Wayne, Indiana
Research Site, Indianapolis, Indiana
Research Site, Des Moines, Iowa
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Baton Rouge, Louisiana
Research Site, Marrero, Louisiana
Research Site, Annapolis, Maryland
Research Site, Baltimore, Maryland
Research Site, Baltimore, Maryland
Research Site, Silver Spring, Maryland
Research Site, Towson, Maryland
Research Site, Detroit, Michigan
Research Site, Hattiesburg, Mississippi
Research Site, Grand Island, Nebraska
Research Site, Lincoln, Nebraska
Research Site, Omaha, Nebraska
Research Site, Belleville, New Jersey
Research Site, Albany, New York
Research Site, East Syracuse, New York
Research Site, Fresh Meadows, New York
Research Site, Westbury, New York
Research Site, Cleveland, Ohio
Research Site, Columbus, Ohio
Research Site, Columbus, Ohio
Research Site, Dayton, Ohio
Research Site, Portland, Oregon
Research Site, Horsham, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Memphis, Tennessee
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Houston, Texas
Research Site, Irving, Texas
Research Site, Lancaster, Texas
Research Site, Fairfax, Virginia
Research Site, Henrico, Virginia
Research Site, Tacoma, Washington
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, Caba, Not set
Research Site, Caba, Not set
Research Site, Ciudad de Córdoba, Not set
Research Site, Córdoba, Not set
Research Site, La Plata, Not set
Research Site, La Plata, Not set
Research Site, Rosario, Not set
Research Site, Clayton, Not set
Research Site, Fitzroy, Not set
Research Site, Heidelberg, Not set
Research Site, South Brisbane, Not set
Research Site, Sydney, Not set
Research Site, Linz, Not set
Research Site, Wels, Not set
Research Site, Aalst, Not set
Research Site, Antwerpen, Not set
Research Site, Gent, Not set
Research Site, Barretos, Not set
Research Site, Curitiba, Not set
Research Site, Florianópolis, Not set
Research Site, Fortaleza, Not set
Research Site, Natal, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio De Janeiro, Not set
Research Site, Santa Cruz do Sul, Not set
Research Site, Sao Paulo, Not set
Research Site, Calgary, Alberta
Research Site, Edmonton, Alberta
Research Site, Winnipeg, Manitoba
Research Site, Halifax, Nova Scotia
Research Site, Barrie, Ontario
Research Site, Oshawa, Ontario
Research Site, Toronto, Ontario
Research Site, Levis, Quebec
Research Site, Trois-Rivières, Quebec
Research Site, Chicoutimi, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Bengbu, Not set
Research Site, Changchun, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Fuzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Hefei, Not set
Research Site, Lanzhou, Not set
Research Site, Linhai, Not set
Research Site, Linyi, Not set
Research Site, Nanchang, Not set
Research Site, Nanchang, Not set
Research Site, Nanjing, Not set
Research Site, Nanning, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenzhen, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Yangzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Olomouc, Not set
Research Site, Ostrava - Vitkovice, Not set
Research Site, Praha, Not set
Research Site, Praha, Not set
Research Site, Angers, Not set
Research Site, Avignon, Not set
Research Site, Bayonne, Not set
Research Site, Bordeaux, Not set
Research Site, Caen, Not set
Research Site, Lille, Not set
Research Site, Limoges, Not set
Research Site, Marseille, Not set
Research Site, Montpellier, Not set
Research Site, Paris Cedex 5, Not set
Research Site, Quimper, Not set
Research Site, Reims, Not set
Research Site, Saint-Malo, Not set
Research Site, Strasbourg Cedex, Not set
Research Site, Suresnes, Not set
Research Site, Toulon Naval, Not set
Research Site, Berlin-Zehlendorf, Not set
Research Site, Bonn, Not set
Research Site, Bonn, Not set
Research Site, Braunschweig, Not set
Research Site, Dresden, Not set
Research Site, Essen, Not set
Research Site, Freiburg, Not set
Research Site, Gauting, Not set
Research Site, Georgsmarienhuette, Not set
Research Site, Gütersloh, Not set
Research Site, Halle, Not set
Research Site, Hamburg, Not set
Research Site, Heidelberg, Not set
Research Site, Immenhausen, Not set
Research Site, Koblenz, Not set
Research Site, Ludwigsburg, Not set
Research Site, Nürnberg, Not set
Research Site, Tuebingen, Not set
Research Site, Velbert, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Deszk, Not set
Research Site, Gyöngyös - Mátraháza, Not set
Research Site, Gyöngyös, Not set
Research Site, Győr, Not set
Research Site, Kecskemét, Not set
Research Site, Pécs, Not set
Research Site, Szekszárd, Not set
Research Site, Székesfehérvár, Not set
Research Site, Törökbálint, Not set
Research Site, Bengaluru, Not set
Research Site, Delhi, Not set
Research Site, Hyderabad, Not set
Research Site, Kolkata, Not set
Research Site, Kolkata, Not set
Research Site, Mysuru, Not set
Research Site, Nagpur, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, Varanasi, Not set
Research Site, Bari, Not set
Research Site, Bergamo, Not set
Research Site, Catanzaro, Not set
Research Site, Milano, Not set
Research Site, Padova, Not set
Research Site, Parma, Not set
Research Site, Pavia, Not set
Research Site, Ravenna, Not set
Research Site, Roma, Not set
Research Site, Roma, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Kashiwa, Not set
Research Site, Kawasaki-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Okayama-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama-shi, Not set
Research Site, Sagamihara-shi, Not set
Research Site, Sapporo-Shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Ube-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Cheongju-si, Not set
Research Site, Daegu, Not set
Research Site, Incheon, Not set
Research Site, Jinju-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Suwon, Not set
Research Site, Ciudad de México, Not set
Research Site, Ciudad de México, Not set
Research Site, Culiacan, Not set
Research Site, Guadalajara, Not set
Research Site, Guadalajara, Not set
Research Site, Mexico City, Not set
Research Site, Monterrey, Not set
Research Site, Naucalpan, Not set
Research Site, Amsterdam, Not set
Research Site, Groningen, Not set
Research Site, Nieuwegein, Not set
Research Site, Tilburg, Not set
Research Site, Lublin, Not set
Research Site, Olsztyn, Not set
Research Site, Poznań, Not set
Research Site, Przemysl, Not set
Research Site, Radom, Not set
Research Site, Rzeszów, Not set
Research Site, Szklarska Poręba, Not set
Research Site, Tomaszów Mazowiecki, Not set
Research Site, Toruń, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Banska Bystrica, Not set
Research Site, Bratislava, Not set
Research Site, Bratislava, Not set
Research Site, Kosice, Not set
Research Site, Trnava, Not set
Research Site, Amanzimtoti, Not set
Research Site, Bloemfontein, Not set
Research Site, George, Not set
Research Site, Johannesburg, Not set
Research Site, Johannesburg, Not set
Research Site, Pietermaritzburg, Not set
Research Site, Pretoria, Not set
Research Site, Rondebosch, Not set
Research Site, Soweto, Not set
Research Site, Alicante, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Bilbao (Vizcaya), Not set
Research Site, Madrid, Not set
Research Site, Málaga, Not set
Research Site, Palma, Not set
Research Site, Hsinchu, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei, Not set
Research Site, Tainan City, Not set
Research Site, Tainan, Not set
Research Site, Taipei City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan, Not set
Research Site, Yunlin, Not set
Research Site, Lampang, Not set
Research Site, Muang, Not set
Research Site, Songkhla, Not set
Research Site, Ankara, Not set
Research Site, Antalya, Not set
Research Site, Diyarbakir, Not set
Research Site, Fatih-Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, İzmir, Not set
Research Site, Pamukkale, Not set
Research Site, Çankaya, Not set
Research Site, Birmingham, Not set
Research Site, Blackpool, Not set
Research Site, Bury St Edmunds, Not set
Research Site, Colchester, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Truro, Not set
Conditions: Metastatic Non-small Cell Lung Cancer
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
Active Not Recruiting
To compare the efficacy of olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian cancer.
To compare the efficacy of olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian cancer. Read Less
Gender:
FEMALE
Ages:
Between 18 years and 125 years
Trial Updated:
08/04/2025
Locations: Research Site, Stanford, California +52 locations
Research Site, Stanford, California
Research Site, West Hollywood, California
Research Site, Orlando, Florida
Research Site, Indianapolis, Indiana
Research Site, Boston, Massachusetts
Research Site, Boston, Massachusetts
Research Site, New York, New York
Research Site, Portland, Oregon
Research Site, Parkville, Not set
Research Site, Randwick, Not set
Research Site, Brussel, Not set
Research Site, Leuven, Not set
Research Site, Namur, Not set
Research Site, Wilrijk, Not set
Research Site, Vancouver, British Columbia
Research Site, Hamilton, Ontario
Research Site, Toronto, Ontario
Research Site, Toronto, Ontario
Research Site, Sherbrooke, Quebec
Research Site, Quebec, Not set
Research Site, Brno, Not set
Research Site, Brno, Not set
Research Site, Hradec Kralove, Not set
Research Site, Olomouc, Not set
Research Site, Praha 2, Not set
Research Site, Essen, Not set
Research Site, Frankfurt, Not set
Research Site, Hamburg, Not set
Research Site, München, Not set
Research Site, Solingen, Not set
Research Site, Genova, Not set
Research Site, Milan, Not set
Research Site, Monza, Not set
Research Site, Torino, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Matsuyama-shi, Not set
Research Site, Morioka-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Yamagata-shi, Not set
Research Site, Yonago-shi, Not set
Research Site, Amsterdam, Not set
Research Site, Amsterdam, Not set
Research Site, Nijmegen, Not set
Research Site, Rotterdam, Not set
Research Site, Ciudad de Panama, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Madrid, Not set
Research Site, Valencia, Not set
Research Site, Birmingham, Not set
Research Site, Coventry, Not set
Research Site, Edinburgh, Not set
Conditions: Ovarian Cancer
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Active Not Recruiting
The goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer.
The goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of participants with certain types of cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/04/2025
Locations: Alaska Oncology and Hematology LLC, Anchorage, Alaska +75 locations
Alaska Oncology and Hematology LLC, Anchorage, Alaska
Cancer & Blood Specialty Clinic, Los Alamitos, California
Moores Cancer Center at the UC San Diego Health, San Diego, California
Yale University Cancer Center, New Haven, Connecticut
ChristianaCare, Newark, Delaware
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida
Florida Cancer Affiliates, Ocala, Florida
Hope and Healing Cancer Services, Hinsdale, Illinois
University of Kentucky, Lexington, Kentucky
Norton Cancer Institute, Louisville, Kentucky
Maryland Oncology Hematology PA, Columbia, Maryland
Washington University School of Medicine, Saint Louis, Missouri
Levine Cancer Center, Charlotte, North Carolina
Novant Health Cancer Institute - Forsyth (Medical Oncology), Winston-Salem, North Carolina
Kaiser Permanente (KP) Oncology/Hematology, Portland, Oregon
University of Pennsylvania, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Sarah Cannon Research Institute, Nashville, Tennessee
Lumi Research, Kingwood, Texas
Utah Cancer Specialists, Salt Lake City, Utah
Virgina Cancer Specialists, Fairfax, Virginia
Adventist Health System/Sunbelt,Inc, Seattle, Washington
Medical Oncology Associates, PS, Spokane, Washington
Rigshospitalet (Copenhagen University Hospital), Copenhagen, Not set
Herlev University Hospital, Herlev, Not set
University Hospital of Southern Denmark, Vejle Hospital, Vejle, Not set
Centre hospitalier Universitaire de Bordeaux, Bordeaux, Not set
Centre Antoine Lacassagne, Nice, Not set
Gustave Roussy, Villejuif, Not set
ARENSIA Research Clinic at the Research Institute of Clinical Medicine, Tbilisi, Not set
Nationales Centrum fr Tumorerkrankungen NCT, Heidelberg, Not set
Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen, Not set
Department of Dermatology, University of Mainz, Mainz, Not set
Universitätsmedizin Mannheim Dermatologie, Mannheim, Not set
Universitaetsklinikum Wuerzburg, Wuerzburg, Not set
Rabin Medical Center, Petah tikva, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv, Not set
Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Not set
Azienda Ospedaliera S.Croce e Carle Cuneo, Cuneo, Not set
Istituto Nazionale dei Tumori, Milan, Not set
Istituto Clinico Humanitas, Rozzano, Not set
Chungbuk National University Hospital, Cheongju-si, Not set
Jeonbuk National University Hospital, Jeonju, Not set
Gachon University Gil Medical Center, Namdong, Not set
Korea University Guro Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Pusan National University Yangsan Hospital, Yangsan, Not set
ARENSIA Research Clinic at the Oncology Institute, Chisinau, Not set
H. Vall d'Hebron, Barcelona, Not set
START Barcelona HM Nou Delfos, Barcelona, Not set
Hospital Duran i Reynals - ICO L Hospitalet, L'Hospitalet De Llobregat, Not set
Hospital Universitario Insular de Gran Canaria, Las Palmas De Gran Canaria, Not set
Hospital Universitario Lucus Augusti, Lugo, Not set
Clinica Universidad de Navarra, Madrid, Not set
HM CIOCC Hospital Universitario HM Sanchinarro, Madrid, Not set
Hospital Clinico San Carlos, Madrid, Not set
Hospital General Universitario Gregorio Maran, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
MD Anderson Cancer Center Madrid, Madrid, Not set
START Madrid - Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario Virgen de la Victoria, Málaga, Not set
Clinica Universidad de Navarra, Pamplona, Not set
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago De Compostela, Not set
Hospital Virgen del Rocio, Sevilla, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Chang Gung Memorial Hospital (CGMH) - Kaohsiung Branch, Kaohsiung City, Not set
Kaohsiung Medical University Memorial Hospital, Kaohsiung City, Not set
China Medical University Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Medical University Hospital, Taipei, Not set
Taipei Veterans General Hospital, VGHTPE, Taipei, Not set
Chang Gung Memorial Hospital Linkou Branch, Taoyuan, Not set
Royal Marsden NHS Foundation Trust, Sutton, Not set
Conditions: Malignant Solid Tumor, Melanoma, Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-Small Cell Lung Cancer (NSCLC)
Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Completed
The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC).
The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Mayo Clinic - Arizona, Phoenix, Arizona +233 locations
Mayo Clinic - Arizona, Phoenix, Arizona
UCLA Hematology/ Oncology, Los Angeles, California
University of California Irvine (UCIMC), Orange, California
MedStar Washington Hospital Center, Washington, District of Columbia
Baptist MD Anderson Cancer Center, Jacksonville, Florida
Boca Raton Clinical Research Global USA - Plantation, Plantation, Florida
University of Iowa Hospitals and Clinics, Iowa City, Iowa
University of Maryland School of Medicine, Baltimore, Maryland
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Montefiore Medical Center, Bronx, New York
Roswell Park Cancer Institute, Buffalo, New York
Weill Cornell Medical College, New York, New York
Cleveland Clinic, Cleveland, Ohio
Oklahoma Cancer Specialists and Research Institute (OCSRI), Tulsa, Oklahoma
Penn State Hershey Cancer Institute, Hershey, Pennsylvania
Thompson Oncology Group - Knoxville Downtown, Knoxville, Tennessee
University Cancer Specialists - Knoxville, Knoxville, Tennessee
Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas
Center for Cancer and Blood Disorders, Fort Worth, Texas
Seattle Cancer Care Alliance (SCCA), Seattle, Washington
Summit Cancer Centers, Spokane, Washington
Chris O'Brien Lifehouse, North Ryde, New South Wales
Calvary Mater Newcastle, Waratah, New South Wales
Westmead Hospital, Westmead, New South Wales
Icon Cancer Centre Wesley, Auchenflower, Queensland
Southern Adelaide Local Health Network Incorporated, Bedford Park, South Australia
Ashford Cancer Centre Research - ICON Cancer Centre Adelaide, Kurralta Park, South Australia
ICON Cancer Centre Hobart, Hobart, Tasmania
Monash Health, Clayton, Victoria
Austin Health, Heidelberg, Victoria
Peter MacCallum Cancer Centre, Melbourne, Victoria
Sunshine Hospital, Saint Albans, Victoria
Liverpool Hospital, Nedlands, Western Australia
Sir Charles Gairdner Hospital, Nedlands, Western Australia
Universitätsklinik für Innere Medizin Graz, Graz, Not set
Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Not set
Krankenhaus Der Barmherzigen Bruder Wien, Wien, Not set
Grand Hôpital De Charleroi - Notre Dame, Charleroi, Not set
Az Maria Middelares Ghent, Gent, Not set
Universitair Ziekenhuis Gent, Gent, Not set
Universitair Ziekenhuis Leuven, Leuven, Not set
Centre Hospitalier Universitaire de Liège, Liège, Not set
Multiprofile Hospital for Active Treatment Heart and Brain EAD, Pleven, Not set
Specialized Hospital for Active Treatment of Oncological Diseases - Sofia District, Sofia, Not set
Cross Cancer Institute, Edmonton, Not set
qeii health sciences centre - VG site, Halifax, Not set
Juravinski Hospital and Cancer Centre, Hamilton, Not set
London Health Sciences Centre, London, Not set
Jewish General Hospital, Montréal, Not set
McGill University Health Centre, Montréal, Not set
R.S. McLaughlin Durham Regional Cancer Centre, Oshawa, Not set
Princess Margaret Cancer Centre, Toronto, Not set
British Columbia Cancer Agency-Vancouver Centre, Vancouver, Not set
Peking University First Hospital, Beijing, Not set
Chinese People's Liberation Army General Hospital - 301 Hospital, Beijing, Not set
Beijing Cancer Hospital, Beijing, Not set
Chinese Academy of Medical Sciences Cancer Hospital, Beijing, Not set
1st Hospital Jilin University, Changchun, Not set
Hunan Cancer Hospital - Xiangya Hospital - Central South University, Changsha, Not set
West China Hospital Sichuan University, Chengdu, Not set
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Not set
Chongqing University Cancer Hospital, Chongqing, Not set
The First Affiliated Hospital of Fujian Medical University, Fujian, Not set
Union Hospital of Fujian Medical University, Fuzhou, Not set
Sun Yat-Sen University Cancer Center, Guangzhou, Not set
Zhejiang Provincial People's Hospital - Zhaohui, Hangzhou, Not set
Cancer Hospital of the University of Chinese Academy of Sciences Zhejiang Cancer Hospital, Hangzhou, Not set
Anhui Provincial Cancer Hospital, Hefei, Not set
Qilu Hospital of Shandong University, Jinan, Not set
The First Affiliated Hospital of Nanchang University, Nanchang, Not set
Nanjing Drum Tower Hospital, Nanjing, Not set
Liaoning Cancer Hospital and Institute, Shenyang, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Not set
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set
Clinical Hospital Centre Split, Split, Not set
Clinical Hospital Centre "Sestre Milosrdnice", Zagreb, Not set
University Hospital Centre Zagreb, Zagreb, Not set
Fakultni nemocnice Olomouc, Olomouc, Not set
Urocentrum Praha, Praha 2, Not set
Ramsay Health Clinic Belharra, Bayonne, Not set
CHU Saint Andre, Bordeaux, Not set
Centre Hospiltalier Universitaire Brest - Hôpital Morvan, Brest, Not set
Centre Francois Baclesse, Caen Cedex 5, Not set
Centre Jean Perrin, Clermont-Ferrand, Not set
Centre Georges- Francois Leclerc, Dijon, Not set
Centre Hospitalier Departemental Vendee, La Roche-Sur-Yon Cedex, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon, Not set
Institut Régional du Cancer de Montpellier ICM Val d' Aurelle, Montpellier, Not set
Centre Antoine Lacassagne, Nice Cedex 2, Not set
Centre Hospitalier Universitaire de Nimes, Nimes, Not set
Hôpital Européen Georges-Pompidou, Paris, Not set
Centre Eugene Marquis, Rennes Cedex, Not set
Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire, Not set
Les Hôpitaux Universitaires de Strasbourg, Strasbourg cedex, Not set
Hôpital Foch, Suresnes, Not set
Institut Claudius Regaud, Toulouse Cedex 9, Not set
Institut Gustave Roussy, Villejuif Cedex, Not set
High Technology Hospital MedCenter, Batumi, Not set
New Hospitals, Tbilisi, Not set
L. Managadze National Center of Urology, Tbilisi, Not set
Evex Medical corporation, Tbilisi, Not set
Jerarsi Clinic, Tbilisi, Not set
Universitatsklinik Dresden, Dresden, Not set
Malteser Waldkrankenhaus Erlangen, Erlangen, Not set
Universitätsklinikum Essen, Essen, Not set
Centrum fur Hamatologie und Onkologie Bethanien, Frankfurt/Main, Not set
Asklepios Klinik Altona, Hamburg, Not set
Institut Für Versorgungsforschung in Der Onkologie, Koblenz, Not set
Universitatsklinikum Munster, Münster, Not set
Studienpraxis Urologie, Nürtingen, Not set
Universitätsklinikum Tübingen, Tübingen, Not set
Charité Universitätsmedizin Berlin - Campus Benjamin Franklin, Wien, Not set
401 General Military Hospital of Athens, Athens, Not set
Henry Dunant Hospital, Athens, Not set
Alexandra General Hospital, Athens, Not set
Attikon Hospital, Chaidari, Not set
Regional University General Hospital of Herakleio, Crete, Herakleio, Not set
University Hospital Of Ioannina, Ioannina, Not set
University Hospital of Larissa, Larisa, Not set
Athens Medical Center, Maroussi, Not set
University Hospital of Patras, Patra, Not set
Bioclinic - Thessaloniki, Thessaloniki, Not set
Theagenio Anticancer Hospital of Thessaloniki, Thessaloniki, Not set
Anassa General Clinic, Thessaloniki, Not set
Interbalkan Medical Center of Thessaloniki, Thessaloniki, Not set
Prince of Wales Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Hong Kong United Oncology Centre, Kowloon, Not set
Tallaght University Hospital, Dublin, Not set
University Hospital Waterford, Waterford, Not set
Shamir Medical Center (Assaf Harofeh), Be'er Ya'akov, Not set
Rambam Health Care Campus, Haifa, Not set
Hadassah University Hospital Ein Kerem, Jerusalem, Not set
Meir Medical Center, Kfar-Sava, Not set
Rabin Medical Center, Petach Tikva, Not set
Tel Aviv Medical Center (Ichilov Hospital), Tel Aviv, Not set
Chaim Sheba Medical Center, Tel Hashomer, Not set
Ospedale San Donato, Arezzo, Not set
Centro di Riferimento Oncologico di Aviano, Aviano, Not set
Istituto Tumori Bari Giovanni Paolo II - IRCCS, Bari, Not set
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia, Candiolo (TO), Not set
Ospedale Policlinico San Martino, Genova, Not set
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Not set
Ospedale San Raffaele, Milan, Not set
Azienda Ospedaliero Universitaria Maggiore Della Carita, Novara, Not set
Azienda Ospedaliero Universitaria Pisana, Pisa, Not set
Istituto Regina Elena, Roma, Not set
Università Campus Bio-Medico di Roma, Rome, Not set
Ospedale Civile Di Sondrio, Sondrio, Not set
Azienda Ospedaliera Santa Maria di Terni, Terni, Not set
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Torino, Not set
Ospedale di Trento - Presidio Ospedaliero Santa Chiara, Trento, Not set
Azienda Ospedaliera Universitaria Integrata Verona, Verona, Not set
Pusan National University Hospital, Busan-si, Not set
Chungbuk National University Hospital, Cheongju, Not set
Chungnam National University Hospital, Daejeon, Not set
National Cancer Center, Goyang-si, Not set
Pusan National University Yangsan Hospital, Gyeongsangnam-do, Not set
Gachon University Gil Medical Center, Incheon, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
The Catholic University of Korea Seoul Saint Mary's Hospital, Seoul, Not set
The Catholic University of Korea Saint Vincent's Hospital, Suwon, Not set
Hospital de Braga, Braga, Not set
Unidade Local de Saúde da Guarda - Hospital Sousa Martins, Guarda, Not set
Centro Hospitalar de Leiria - Hospital de Santo André, Leiria, Not set
Centro Hospitalar de Lisboa Norte - Hospital de Santa Maria, Lisbon, Not set
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E, Porto, Not set
Centro Hospitalar de Tras-os-Montes e Alto Douro, Vila Real, Not set
BRCR Medical Center, Inc, San Juan, Not set
National University Hospital, Singapore, Not set
Icon Cancer Centre Farrer Park, Singapore, Not set
Tan Tock Seng Hospital, Singapore, Not set
Hospital del Mar - Parc de Salut, Barcelona, Not set
Hospital Universitari Vall D'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital Reina Sofia, Córdoba, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Clínica Universidad de Navarra - Madrid, Madrid, Not set
MD Anderson Cancer Center, Madrid, Not set
Hospital Universitario Ramon y Cajal, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set
Hospital Sant Joan de Déu de Manresa, Manresa, Not set
Complexo Hospitalario de Ourense (CHOU), Ourense, Not set
Clinica Universidad de Navarra, Pamplona, Not set
Hospital Universitario Marqués de Valdecilla, Santander, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Álvaro Cunqueiro Hospital, Vigo, Not set
Länssjukhuset Ryhov, Jönköping, Not set
Universitetssjukhuset i Linköping, Linköping, Not set
Karolinska Universitetssjukhuset - Solna, Stockholm, Not set
University Hospital Basel, Basel, Not set
Istituto Oncologico Della Svizzera Italiana (IOSI), Bellinzona, Not set
University of Bern, Bern, Not set
Hôpitaux Universitaires de Genève, Geneva, Not set
Universitaetsspital Zurich - Klinik fur Medizinische Onkologie und Hematologie, Zurich, Not set
Kaohsiung Veterans General Hospital, Kaohsiung, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
Taipei Tzu Chi General Hospital, New Taipei City, Not set
Chiayi Chang Gung Memorial Hospital, Puzi, Not set
China Medical University Hospital, Taichung City, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei City, Not set
Taipei Veterans General Hospital, Taipei City, Not set
Chang Gung Memorial Hospital - Linkou Branch, Taoyuan, Not set
Hacettepe Universitesi Tip Fakultesi- Kanser Enstitusu, Ankara, Not set
Trakya Universitesi Saglik Arastirma ve Uygulama Merkezi, Edirne, Not set
Bagcilar Medipol Mega Universite Hastanesi, Istanbul, Not set
Istanbul Acibadem University Maslak Hospital, Istanbul, Not set
T.C. Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set
Medical Park Izmır Hastanesi, İzmir, Not set
Cebeci Hastanesi, Mamak, Not set
VKV Amerikan Hastanesi Department of Oncology, Şişli, Not set
University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set
Dorset County Hospital NHS Foundation Trust, Dorchester, Not set
NHS Greater Glasgow and Clyde, Glasgow, Not set
Barts Health NHS Trust, London, Not set
Guys and Saint Thomas NHS Foundation Trust, Guy's Hospital, London, Not set
Sarah Cannon Research Institute London, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
East and North Hertfordshire NHS Trust, Middlesex, Not set
Oxford University Hospitals NHS Foundation Trust, Oxford, Not set
Swansea Bay University Health Board, Port Talbot, Not set
Royal Preston Hospital, Preston, Not set
The Royal Marsden NHS Foundation Trust, Surrey, Not set
The Royal Wolverhampton NHS Trust, Wolverhampton, Not set
Conditions: Locally Advanced or Metastatic Unresectable Urothelial Cancer
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Active Not Recruiting
A Phase 2/3 Study of Evorpacept (ALX148) in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Patients With Advanced HER2-overexpressing gastric/GEJ adenocarcinoma.
A Phase 2/3 Study of Evorpacept (ALX148) in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Patients With Advanced HER2-overexpressing gastric/GEJ adenocarcinoma. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: The Oncology Institute of Hope & Innovation, Anaheim, California +82 locations
The Oncology Institute of Hope & Innovation, Anaheim, California
University of California Los Angeles, Los Angeles, California
Vanderbilt University Medical Center, Nashville, Tennessee
NEXT Virginia, Fairfax, Virginia
Fred Hutchinson Cancer Center, Seattle, Washington
Icon Cancer Centre Southport, Southport, Queensland
Monash Medical Centre, Clayton, Victoria
Universitair Ziekenhuis Antwerpen, Antwerp, Not set
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Not set
Centre Hospitalier Universitaire de Liège, Liège, Not set
Fakultní Nemocnice Hradec Králové, Hradec Králové, Not set
Fakultní Nemocnice Olomouc, Olomouc, Not set
Vseobecna Fakultni Nemocnice v Praze, Prague, Not set
Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz, Besançon, Not set
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, Not set
Hôpital Morvan, Brest, Not set
Centre Léon Bérard, Lyon, Not set
Hôpital Privé Jean Mermoz, Lyon, Not set
Institut Paoli-Calmettes, Marseille, Not set
Hôpital Saint-Antoine, Paris, Not set
Hôpital Trousseau, Paris, Not set
Hôpital Rangueil, Toulouse, Not set
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Not set
Azienda Ospedaliero - Universitaria Careggi, Florence, Not set
Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano, Not set
Policlinico Universitario Campus Bio-Medico, Roma, Not set
Azienda Sanitaria Universitaria Friuli Centrale - P.O. Santa Maria della Misericordia, Udine, Not set
National Cancer Center Hospital East, Chiba, Not set
Kyushu Cancer Center, Fukuoka, Not set
Gifu University Hospital, Gifu, Not set
Japanese Red Cross Kumamoto Hospital, Kumamoto, Not set
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Not set
Nagasaki University Hospital, Nagasaki, Not set
Osaka Prefectural Hospital Organization - Osaka International Cancer Institute, Osaka, Not set
Kindai University Hospital, Osaka, Not set
Saitama Cancer Center, Saitama, Not set
Tohoku University Hospital, Sendai, Not set
Shizuoka Cancer Center, Shizuoka, Not set
National Cancer Center Hospital, Tokyo, Not set
Cancer Institute Hospital of JFCR, Tokyo, Not set
Kanagawa Cancer Center, Yokohama, Not set
Oita University Hospital - Hasama Campus, Ōita, Not set
Inje University Haeundae Paik Hospital, Busan, Not set
Dong-A University Hospital, Busan, Not set
Pusan National University Hospital, Busan, Not set
Yeungnam University Medical Center, Daegu, Not set
Chungnam National University Hospital, Daejeon, Not set
Hallym University Sacred Heart Hospital, Dongan, Not set
National Cancer Center - Korea, Goyang-si, Not set
Jeonbuk National University Hospital, Jeonju, Not set
Seoul National University Bundang Hospital, Seongnam, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Severance Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Boramae Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
The Catholic University of Korea Saint Vincent's Hospital, Suwon, Not set
National Cancer Centre Singapore, Singapore, Not set
Icon Cancer Centre Farrer Park, Singapore, Not set
Hospital General Universitario de Elche, Alicante, Not set
Hospital Germans Trias i Pujol, Badalona, Not set
Hospital Quirónsalud Barcelona, Barcelona, Not set
Hospital Universitari Vall d'Hebrón, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital Universitario Reina Sofía, Córdoba, Not set
Hospital Universitario Lucus Augusti, Lugo, Not set
Hospital Universitario Ramón y Cajal, Madrid, Not set
Hospital Universitario Marqués de Valdecilla, Santander, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
Koo Foundation Sun Yat-Sen Cancer Center, Beitou, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Chi Mei Hospital - Liouying, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Royal Free Hospital, London, Not set
Guy's and Saint Thomas' NHS Foundation Trust, London, Not set
The Royal Marsden Hospital, London, Not set
Conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
Recruiting
This study is a Phase II, multi-site, randomized, open-label clinical study to evaluate the safety, efficacy, and pharmacokinetics (PK) of BNT327 at two dose levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple-negative breast cancer (mTNBC).
This study is a Phase II, multi-site, randomized, open-label clinical study to evaluate the safety, efficacy, and pharmacokinetics (PK) of BNT327 at two dose levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple-negative breast cancer (mTNBC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: Arizona Oncology Associates, PC, Tucson, Arizona +61 locations
Arizona Oncology Associates, PC, Tucson, Arizona
Beverly Hills Cancer Center, Beverly Hills, California
Valkyrie Clinical Trials, Los Angeles, California
Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto, California
Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica, California
Rocky Mountain Cancer Centers (RMCC), Denver, Colorado
Yale University - Yale Cancer Center, New Haven, Connecticut
Hematology Oncology Associates of Treasure Coast, Port Saint Lucie, Florida
Kaiser Permanente - Moanalua Medical Center And Clinic, Honolulu, Hawaii
Orchard Healthcare Research Inc., Skokie, Illinois
Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana, Illinois
Northwest Cancer Centers, P.C., Dyer, Indiana
Community Health Network, Indianapolis, Indiana
Helen G. Nassif Community Cancer Center, Cedar Rapids, Iowa
Henry Ford Hospital, Detroit, Michigan
HealthPartners Regions Specialty Clinics, Saint Louis Park, Minnesota
Minnesota Oncology - Woodbury Clinic, Woodbury, Minnesota
Bozeman Health Deaconess Hospital Cancer Center, Bozeman, Montana
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), New Brunswick, New Jersey
Stony Brook University Hospital, Stony Brook, New York
Clinical Research Alliance Inc., Westbury, New York
FirstHealth Outpatient Cancer Center, Pinehurst, North Carolina
The West Clinic, P.C. d/b/a West Cancer Center, Germantown, Tennessee
University of Tennessee Medical Center, Knoxville, Tennessee
SCRI Oncology Partners, Nashville, Tennessee
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas
Ut Health Science Center - San Antonio (UTHSCSA), Cancer Therapy & Research Center, San Antonio, Texas
Bon Secours St. Francis Medical Center, Midlothian, Virginia
Virginia Oncology Associates, Norfolk, Virginia
Northwest Cancer Specialists, Vancouver, Washington
Icon Cancer Care, Wesley Clinic, Auchenflower, Not set
Peninsula Oncology Centre, Frankston, Not set
Peter MacCallum Cancer Centre, Melbourne, Not set
Mater Hospital Sydney, Sydney, Not set
Westmead Hospital, Westmead, Not set
Baskent Universitesi Tip Fakultesi Adana Hastanesi, Adana, Not set
Medical Park Seyhan Hospital, Adana, Not set
Adana City Training and Research Hospital, Adana, Not set
Sakarya University - Faculty of Medicine, Adapazarı, Not set
Gulhane Egitim ve Arastirma Hastanesi, Ankara, Not set
Hacettepe Universitesi Kanser Enstitusu, Ankara, Not set
Sbu Dr.A.Y. Ankara Onkoloji SUAM, Ankara, Not set
Memorial Ankara Hospital, Ankara, Not set
Ankara City Hospital, Ankara, Not set
Gaziantep Sanko University Medical Faculty, Gaziantep, Not set
Koc Universitesi Hastanesi (Koc University Hospital), Istanbul, Not set
Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi, Istanbul, Not set
Istinye Universitesi Bahcesehir Liv Hospital, Istanbul, Not set
Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set
Yeditepe University Hospital, Istanbul, Not set
Medical Point Izmir Hospital, İzmir, Not set
Ondokuz Mayis Universitesi Tip Fakultesi, Samsun, Not set
Acibadem Adana Hospital, Seyhan, Not set
Gazi University Medical Faculty, Yenimahalle, Not set
Stoke Mandeville Hospital - Buckinghamshire Healthcare NHS Trust, Aylesbury, Not set
Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Hospital, Cottingham, Not set
Edinburgh Cancer Centre-Western General Hospital, Edinburgh, Not set
St James's University Hospital - Leeds Teaching Hospitals NHS Trust, Leeds, Not set
St Bartholomew's Hospital - Barts Health NHS Trust, London, Not set
University College London Hospitals NHS Foundation Trust, London, Not set
Sarah Cannon Research Institute, London, Not set
Nottingham University Hospitals NHS Trust, Nottingham, Not set
Conditions: Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Active Not Recruiting
The purpose of this study was to compare the overall survival (OS) of participants with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin (EV) to the OS of participants treated with chemotherapy.
This study compared progression-free survival on study therapy (PFS1); the overall response rate (ORR) and the disease control rate (DCR) per Response Evaluation Criteria in Solid Tumors (RECIST) V1.1 of participants treated with EV to participants treated with chemothera... Read More
The purpose of this study was to compare the overall survival (OS) of participants with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin (EV) to the OS of participants treated with chemotherapy.
This study compared progression-free survival on study therapy (PFS1); the overall response rate (ORR) and the disease control rate (DCR) per Response Evaluation Criteria in Solid Tumors (RECIST) V1.1 of participants treated with EV to participants treated with chemotherapy.
In addition, this study evaluated the duration of response (DOR) per RECIST V1.1 of EV and chemotherapy and assessed the safety and tolerability of EV, as well as, the quality of life (QOL) and Patient Reported Outcomes (PRO) parameters. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: UCI Chao Family Comprehensive Cancer Center, Orange, California +157 locations
UCI Chao Family Comprehensive Cancer Center, Orange, California
University of California, Sacramento, California
Innovative Clinical Research, Whittier, California
University of Colorado, Denver, Colorado
Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut
Sylvester Comprehensive Cancer Center, Miami, Florida
Florida Hospital, Orlando, Florida
Rush University Medical Center, Chicago, Illinois
Norton Cancer Institute, Louisville, Kentucky
Dana-Farber Cancer Institute, Boston, Massachusetts
Nebraska Cancer Specialists, Omaha, Nebraska
Montefiore Medical Center, Bronx, New York
Roswell Park Cancer Institute, Buffalo, New York
Long Island Jewish Medical Center, Lake Success, New York
Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York
White Plains Hospital Center for Cancer Care - Oncology Site, White Plains, New York
Toledo Clinic Cancer Center, Toledo, Ohio
Providence Portland Med Center, Portland, Oregon
University of Pennsylvania, Philadelphia, Pennsylvania
Fox Chase Cancer Center, Philadelphia, Pennsylvania
Lifespan Rhode Island Hospital, Providence, Rhode Island
Saint Francis Hospital, Greenville, South Carolina
HOPE Cancer Center of East Texas, Tyler, Texas
Benaroya Research Institute at Virginia Mason, Seattle, Washington
Medical College of Wisconsin, Milwaukee, Wisconsin
Site AR54001, Buenos Aires, Not set
Site AU61006, Adelaide, Not set
Site AU61001, Miranda, Not set
Site AU61004, St. Leonards, Not set
Site AU61002, Sydney, Not set
Site AT43005, Linz, Not set
Site AT43001, Salzburg, Not set
Site AT43004, Wien, Not set
Site BE32011, Aalst, Not set
Site BE32007, Brussels, Not set
Site BE32013, Brussels, Not set
Site BE32010, Charleroi, Not set
Site BE32001, Gent, Not set
Site BE32008, Gent, Not set
Site BE32005, Hasselt, Not set
Site BE32003, Leuven, Not set
Site BE32009, Liège, Not set
Site CA15015, Calgary, Not set
Site CA15012, Edmonton, Not set
Site CA15014, London, Not set
Site CA15002, Montreal, Not set
Site CA15007, Montreal, Not set
Site CA15011, Oshawa, Not set
Site CA15004, Quebec, Not set
Site CA15008, Saskatoon, Not set
Site CA15001, Sherbrooke, Not set
Site CA15005, Toronto, Not set
Site CA15013, Vancouver, Not set
Site DK45003, Aalborg, Not set
Site DK45004, Copenhagen, Not set
Site DK45001, Herlev, Not set
Site FR33021, Besancon, Not set
Site FR33009, Bordeaux, Not set
Site FR33018, Bordeaux, Not set
Site FR33001, Brest, Not set
Site FR33016, Caen, Not set
Site FR33015, Lyon, Not set
Site FR33014, Marseille, Not set
Site FR33003, Nice, Not set
Site FR33022, Paris, Not set
Site FR33005, Pierre-Bénite, Not set
Site FR33004, Saint-Mande, Not set
Site FR33002, Strasbourg, Not set
Site FR33019, Toulouse, Not set
Site FR33006, Villejuif, Not set
Site DE49011, Essen, Not set
Site DE49008, Heidelberg, Not set
Site DE49010, Münster, Not set
Site DE49003, Tübingen, Not set
Site DE49009, Würzburg, Not set
Site IT39008, Arezzo, Not set
Site IT39019, Cremona, Not set
Site IT39010, Milan, Not set
Site IT39025, Modena, Not set
Site IT39013, Pisa, Not set
Site IT39014, Reggio Emilia, Not set
Site IT39004, Terni, Not set
Site JP81010, Hirosaki, Aomori
Site JP81014, Kashiwa, Chiba
Site JP81007, Sapporo, Hokkaido
Site JP81026, Sapporo, Hokkaido
Site JP81020, Tsukuba, Ibaraki
Site JP81018, Morioka, Iwate
Site JP81009, Kita-gun, Kagawa
Site JP81002, Yokohama, Kanagawa
Site JP81005, Sendai, Miyagi
Site JP81016, Osakasayama, Osaka
Site JP81024, Takatsuki, Osaka
Site JP81008, Bunkyo-ku, Tokyo
Site JP81012, Koto-ku, Tokyo
Site JP81013, Shinjuku-ku, Tokyo
Site JP81011, Ube, Yamaguchi
Site JP81015, Chiba, Not set
Site JP81019, Fukuoka, Not set
Site JP81023, Fukuoka, Not set
Site JP81004, Hiroshima, Not set
Site JP81001, Kyoto, Not set
Site JP81017, Niigata, Not set
Site JP81003, Okayama, Not set
Site JP81022, Osaka, Not set
Site JP81021, Tokushima, Not set
Site JP81006, Toyama, Not set
Site KR82006, Daejeon, Not set
Site KR82007, Goyang-Si, Not set
Site KR82012, Hwasun-gun, Not set
Site KR82002, Incheon, Not set
Site KR82001, Seongnam-si, Not set
Site KR82003, Seoul, Not set
Site KR82004, Seoul, Not set
Site KR82008, Seoul, Not set
Site KR82009, Seoul, Not set
Site KR82010, Seoul, Not set
Site KR82005, Shin, Not set
Site NL31002, Amsterdam, Not set
Site NL31003, Amsterdam, Not set
Site NL31009, Nijmegen, Not set
Site NL31001, Tilburg, Not set
Site PT35105, Lisboa, Not set
Site PT35102, Lisbon, Not set
Site PT35106, Porto, Not set
Site RU70002, Ivanovo, Not set
Site RU70009, Obninsk, Not set
Site RU70005, Omsk, Not set
Site RU70015, Vologda, Not set
Site ES34010, Badajoz, Not set
Site ES34002, Badalona, Not set
Site ES34001, Barcelona, Not set
Site ES34012, Barcelona, Not set
Site ES34023, Barcelona, Not set
Site ES34014, Córdoba, Not set
Site ES34003, Madrid, Not set
Site ES34013, Madrid, Not set
Site ES34015, Madrid, Not set
Site ES34017, Madrid, Not set
Site ES34011, Manresa, Not set
Site ES34019, Pamplona, Not set
Site ES34005, Seville, Not set
Site ES34007, Valencia, Not set
Site ES34008, Valencia, Not set
Site CH41002, Bern, Not set
Site CH41001, Chur, Not set
Site TW88602, Kaohsiung, Not set
Site TW88605, Kaohsiung, Not set
Site TW88606, Taichung, Not set
Site TW88601, Tainan, Not set
Site TW88604, Taipei, Not set
Site TW88607, Taoyuan, Not set
Site GB44005, London, Not set
Site GB44006, London, Not set
Site GB44002, Sheffield, Not set
Site GB44011, Southampton, Not set
Site GB44013, Sutton, Not set
Site GB44004, Wirral, Not set
Conditions: Ureteral Cancer, Urothelial Cancer, Bladder Cancer
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Recruiting
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients.
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2025
Locations: Mayo Clinic Arizona - Phoenix Campus, Phoenix, Arizona +132 locations
Mayo Clinic Arizona - Phoenix Campus, Phoenix, Arizona
University of Arizona Cancer Center, Tucson, Arizona
University of California San Diego Health, La Jolla, California
Cancer & Blood Specialty Clinic - Los Alamitos, Los Alamitos, California
Keck Medicine of USC - Keck Hospital of USC, Los Angeles, California
Sutter Medical Center, Roseville, California
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
UCLA Health - Santa Monica Cancer Care, Santa Monica, California
UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, Colorado
USOR - Rocky Mountain Cancer Centers - Denver - Midtown, Denver, Colorado
Yale Cancer Center, New Haven, Connecticut
Mayo Clinic - Jacksonville, Jacksonville, Florida
Miami Cancer Institute, Miami, Florida
Piedmont Cancer Institute, Atlanta, Georgia
Emory University Hospital, Atlanta, Georgia
USOR - Illinois Cancer Specialists - Arlington Heights, Arlington Heights, Illinois
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
University of Chicago, Chicago, Illinois
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Cancer Center of Kansas - Medical Arts Tower, Wichita, Kansas
Mary Bird Perkins Cancer Center - Baton Rouge, Baton Rouge, Louisiana
Maine Medical Center, Portland, Maine
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Cancer & Hematology Centers of Western Michigan - Lemmen-Holton Cancer Pavilion, Grand Rapids, Michigan
HealthPartners Cancer Research Center - Cancer Center at Regions Hospital, Minneapolis, Minnesota
Mayo Clinic - Rochester, Rochester, Minnesota
MediSync Clinical Research - Hattiesburg Clinic, Hattiesburg, Mississippi
Saint Luke's Hospital of Kansas City, Kansas City, Missouri
University of Nebraska Medical Center, Omaha, Nebraska
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico
Roswell Park Comprehensive Cancer Center, Buffalo, New York
Clinical Research Alliance, New Hyde Park, New York
New York University Medical Oncology Associates, New York, New York
Columbia University Irving Medical Center - Herbert Irving Pavilion, New York, New York
Memorial Sloan-Kettering Cancer Center - New York - Rockefeller Outpatient Pavilion, New York, New York
Mount Sinai Medical Center Comprehensive Cancer Center, New York, New York
James P. Wilmot Cancer Center, Rochester, New York
University Hospitals Cleveland Medical Center, Cleveland, Ohio
Stephenson Cancer Center, Oklahoma City, Oklahoma
Fox Chase Cancer Center, Philadelphia, Pennsylvania
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania
SCRI Oncology Partners, Nashville, Tennessee
Vanderbilt University Medical Center, Nashville, Tennessee
USOR - Texas Oncology - Austin Midtown, Austin, Texas
USOR - Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center, Dallas, Texas
University of Texas Southwestern Medical Center, Dallas, Texas
University of Texas MD Anderson Cancer Center, Houston, Texas
USOR - Texas Oncology - San Antonio Medical Center, San Antonio, Texas
USOR - Texas Oncology - Deke Slayton Cancer Center, Webster, Texas
Inova Medical Group - Hematology Oncology - Arlington, Fairfax, Virginia
Virginia Mason Medical Center, Seattle, Washington
Summit Cancer Centers - Spokane Valley, Spokane, Washington
USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver, Washington
University of Wisconsin - Madison, Madison, Wisconsin
Chris O'Brien Lifehouse, Camperdown, Not set
Monash Health, Clayton, Not set
Oncology West - Murdoch, Murdoch, Not set
Wollongong Hospital, Wollongong, Not set
Salzburg Cancer Research Institute, Salzburg, Not set
Universitätsklinikum Sankt Pölten, Sankt Pölten, Not set
Krankenhaus Der Barmherzigen Brüder Wien, Wien, Not set
Medizinische Universität Wien, Wien, Not set
Institut Jules Bordet, Anderlecht, Not set
Imeldaziekenhuis, Bonheiden, Not set
Algemeen Ziekenhuis Groeninge - Campus Kennedylaan, Kortrijk, Not set
Ottawa Hospital - General Campus, Ottawa, Not set
Hôtel-Dieu de Sherbrooke, Sherbrooke, Not set
Princess Margaret Cancer Centre, Toronto, Not set
Sunnybrook Health Sciences Centre - Bayview Campus, Toronto, Not set
Nemocnice AGEL Nový Jičín a.s., Nový Jičín, Not set
Fakultni nemocnice v Motole, Praha, Not set
Centre Georges François Leclerc, Dijon cedex, Not set
Hôpital Huriez, Lille Cedex, Not set
Centre Léon Bérard, Lyon, Not set
Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set
Gustave Roussy, Villejuif, Not set
Katholisches Klinikum Bochum - St. Josef-Hospital, Bochum, Not set
Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Universitätsklinikum Düsseldorf, Düsseldorf, Not set
Krankenhaus Nordwest, Frankfurt am Main, Not set
Asklepios Klinik Altona, Hamburg, Not set
Facharztzentrum Eppendorf, Hamburg, Not set
Katholisches Marienkrankenhaus, Hamburg, Not set
Medizinische Hochschule Hannover, Hannover, Not set
SLK-Kliniken Heilbronn - Klinikum am Gesundbrunnen, Heilbronn, Not set
Elblandklinikum Riesa, Riesa, Not set
Universitätsklinikum Ulm, Ulm, Not set
Universitätsklinikum Würzburg, Wuerzburg, Not set
Azienda Ospedaliero-Universitaria di Bologna - Policlinico Sant Orsola-Malpighi, Bologna, Not set
Ospedale di Cremona, Cremona, Not set
Azienda Ospedaliero - Universitaria Careggi, Firenze, Not set
Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano, Not set
Istituto Europeo di Oncologia, Milano, Not set
Azienda Ospedaliero - Universitaria di Modena, Modena, Not set
Istituto Oncologico Veneto - IRCCS, Padova, Not set
Ospedale Guglielmo da Saliceto, Piacenza, Not set
IRCCS Istituto Nazionale Tumori Regina Elena, Roma, Not set
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Istituto Clinico Humanitas, Rozzano, Not set
Azienda Ospedaliero Universitaria Delle Marche, Torrette, Not set
Azienda Ospedaliera Universitaria Integrata Verona, Verona, Not set
National Cancer Center Hospital East, Kashiwa-shi, Not set
Cancer Institute Hospital of JFCR, Koto, Not set
Osaka Prefectural Hospital Organization - Osaka International Cancer Institute, Osaka, Not set
National Cancer Center Hospital, Tokyo, Not set
Toyama University Hospital, Toyama, Not set
Yamaguchi University Hospital, Ube, Not set
Kanagawa Cancer Center, Yokohama-Shi, Not set
Chonnam National University Hwasun Hospital, Hwasun, Not set
Cha Bundang Medical Center, Seongnam, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Seoul, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital Universitari Vall d'Hebrón, Barcelona, Not set
Hospital General Universitario de Elche, Elche, Not set
Institut Català d'Oncologia Girona (ICO Girona), Girona, Not set
Clínica Universidad de Navarra - Madrid, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario HM Sanchinarro, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Clinica Universidad de Navarra - Pamplona, Pamplona, Not set
Hospital Universitario de Navarra, Pamplona, Not set
Consorci Hospital General Universitari de València, Valencia, Not set
Hospital Alvaro Cunqueiro - Clinico Universitario Vigo, Vigo, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
Hull University Teaching Hospitals NHS Trust, Cottingham, Not set
Royal Free London NHS Foundation Trust, London, Not set
Sarah Cannon Research Institute London, London, Not set
University College London Hospitals NHS Foundation Trust, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
University Hospitals Birmingham NHS Foundation Trust, Oxford, Not set
Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Recruiting
This is a phase III, single-arm, multicenter, international study to assess the efficacy and safety of ONCOFID-P-B following intravesical instillation in adult patients with histologically and cytologically confirmed CIS, with or without concomitant Ta-T1, who are unresponsive to BCG therapy and unwilling or unfit to undergo radical cystectomy.
After providing written informed consent (in presence of an Independent Witness, if applicable), patients will receive an induction therapy consisting o... Read More
This is a phase III, single-arm, multicenter, international study to assess the efficacy and safety of ONCOFID-P-B following intravesical instillation in adult patients with histologically and cytologically confirmed CIS, with or without concomitant Ta-T1, who are unresponsive to BCG therapy and unwilling or unfit to undergo radical cystectomy.
After providing written informed consent (in presence of an Independent Witness, if applicable), patients will receive an induction therapy consisting of 12 weekly intravesical instillations of ONCOFID-P-B (induction phase). Patients with residual CIS at the end of induction treatment are eligible to enter a re-induction course of therapy (reinduction phase). Patients with stable disease by Investigator assessment defined as neither increased or decreased in extent or severity compared to baseline, are not eligible for re-induction therapy. Patients who achieve a complete resonde (CR) at the end of the induction or re-induction phase enter in the maintenance phase and receive monthly intravesical instillations of ONCOFID-P-B for an additional 12 monsthe or untile recurrence of CIS/HG Ta-T1 or progression to MIBC or extravesical disease. Patients who do not achieve a CR at the end of induction or re-induction phase, will discontinue investigational treatement and are followed up until month 48 from induction or re-induction start, or until a new antitumor therapy is initiated, wichever occurs first.
Tumor response is evaluated by cystoscopy, cytology and biopsy at the end of the induction and re-induction phases and at Safety Follow Up Visit (SFUV). During the maintenance/follow-up period, tumorresponse is evaluated by cystoscopy and cytology every 3 months for up to 24 months from induction or re-induction start, and then every 6 months for an additional 2 years (long-term follow-up). Tumor biopsies are performed in case of of positive cystoscopy and/or cytology. Random biopsies are to be performed at 6, 12 and 18 months after the end of the induction or re-induction phase in responding patients (i.e. at 9, 15 and 21 months after induction or re-induction start. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2025
Locations: Banner Health- MD Anderson Cancer Center, Gilbert, Arizona +45 locations
Banner Health- MD Anderson Cancer Center, Gilbert, Arizona
Ochsner Clinic Foundation, New Orleans, Louisiana
Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland
University of Minnesota, Minneapolis, Minnesota
Medical University of South Carolina (MUSC), Charleston, South Carolina
CHU Bordeaux -Hopital Pellegrin, Bordeaux, Not set
CHU de Clermont-Ferrand - Hopital Gabriel Montpied, Clermont-Ferrand, Not set
CHU de Lille - Hopital Claude Huriez, Lille, Not set
Institute Paoli-Calmettes, Marseille, Not set
AP-HP Hopital Bichat-Claude Bernard, Paris, Not set
AP-HP Hopital Tenon, Paris, Not set
Centre Hospitalier Universitaire Poitiers, Poitiers, Not set
Humanitas Gavazzeni, Bergamo, Not set
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna, Not set
Istituto Oncologico Veneto-I.R.C.C.S.-Ospedale San Giacomo, Castelfranco Veneto, Not set
Azienda Ospedaliero-Universitaria Careggi, Firenze, Not set
ASL Lecce- Ospedale Vito Fazzi, Lecce, Not set
Istituto Clinico Humanitas, Milano, Not set
IRCSS Ospedale San Raffaele, Milano, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Not set
IFO-Istituto Nazionale dei Tumori Regina Elena, Roma, Not set
AOU Città della Salute e della Scienza di Torino-Ospedale le Molinette, Torino, Not set
Azienda Ospedaliera Universitaria Integrata Verona-Ospedale Borgo Trento, Verona, Not set
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli, Oddzial Urologiczny, Lublin, Not set
Wojewodzki Szpital im Sw. Ojca Pio w Przemyslu, Oddzial Urologiczny z Pododdzialem Urologii Onkologicznej, Przemyśl, Not set
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher, Warszawa, Not set
Vall d'Hebron Barcelona Hospital, Barcelona, Not set
Hospital Clinic Barcelona, Barcelona, Not set
Hospital Universitari de Bellvitge, Barcelona, Not set
Hospital Universitario de Basurto, Bilbao, Not set
Hospital Universitario Reina Sofia, Córdoba, Not set
Hospital Universitario Virgen de las Nieves, Granada, Not set
Hospital Fundación Jimenez Diaz, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Centro Integral Oncologico Clara Campal, Madrid, Not set
Hospital Universitario Fundacion Alcorcon, Madrid, Not set
Hospital Universitario Virgen de la Victoria, Malaga, Not set
Instituto Valenciano de Oncologia, Valencia, Not set
Darent Valley Hospital, Dartford, Kent
Huddersfield Royal Infirmary, Huddersfield, Not set
St James's University Hospital, Leeds, Not set
Barts Health NHS Trust, London, Not set
Derriford Hospital, Plymouth, Not set
Royal Preston Hospital, Preston, Not set
Royal Marsden Hospital - Surrey, Sutton, Not set
Conditions: Bladder Carcinoma in Situ (CIS)
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Completed
The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC).
The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/28/2025
Locations: Smilow Cancer Hospital At Yale, New Haven, Connecticut +123 locations
Smilow Cancer Hospital At Yale, New Haven, Connecticut
Renovatio Clinical, The Woodlands, Texas
Coffs Harbour Base Hospital, Coffs Harbour, New South Wales
St Vincents Hospital Melbourne, Fitzroy, Victoria
Institut Jules Bordet, Anderlecht, Not set
Az Sint Jan Brugge, Brugge, Not set
Grand Hopital de Charleroi Site Notre Dame, Charleroi, Not set
UZ GENT, Gand, Not set
University Hospitals Leuven, Leuven, Not set
Chc Montlegia, Liege, Not set
Anhui Provincial Hospital, Hefei, Anhui
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei, Anhui
The Second Hospital of Anhui Medical University, Hefei, Anhui
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing
The Fifth Medical Center of Chinese Pla General Hospital, Beijing, Beijing
Beijing Cancer Hospital, Beijing, Beijing
Peking Union Medical College Hospital, Beijing, Beijing
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian
Fujian Cancer Hospital, Fuzhou, Fujian
Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou, Fujian
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian
Zhongshan Hospital Xiamen University, Xiamen, Fujian
The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong
Guangdong Province Traditional Chinese Medical Hospitsal, Guangzhou, Guangdong
The Sixth Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
The Tumor Hospital Affiliated to Guangxi Medical University, Nanning, Guangxi
Hainan General Hospital, Haikou, Hainan
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan
Henan Cancer Hospital, Zhengzhou, Henan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
Hubei Cancer Hospital, Wuhan, Hubei
Xiangyang Central Hospital, Xiangyang, Hubei
Hunan Cancer Hospital, Changsha, Hunan
The First Peoples Hospital of Changzhou, Changzhou, Jiangsu
Jiangsu Province Hospital, Nanjing, Jiangsu
Nantong Tumor Hospital Branch North, Nantong, Jiangsu
Affiliated Hospital of Jiangnan University North Campus (Wuxi Fourth Peoples Hospital ), Wuxi, Jiangsu
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning
Shandong Cancer Hospital, Jinan, Shandong
Linyi Cancer Hospital, Linyi, Shandong
Weifang Peoples Hospital, Weifang, Shandong
Fudan University Shanghai Cancer Center, Shanghai, Shanghai
Shanxi Provincial Peoples Hospital, Taiyuan, Shanxi
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Fakultni Thomayerova Nemocnice, Praha, Not set
Chru de Brest Hopital Cavale Blanche, Brest, Not set
Chu Besancon Hopital Jean Minjoz, Doubs, Not set
Hopital Franco Britannique, LevalloisPerret, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon Cedex, Not set
Hopital Saint Antoine Service Dhepato Gastro Enterologie, Paris Cedex, Not set
Hopital Europeen Georges Pompidou, Paris, Not set
Chu Bordeaux Hopital Haut Leveque, Pessac, Not set
Chu de Poitiers Site de La Mileterie, Poitiers, Not set
Centre de Lutte Contre Le Cancer Institut de Cancerologie de Louest Rene Gauducheau, SaintHerblain, Not set
Universitatsklinikum Hamburg Eppendorf, Hamburg, Not set
Slk Kliniken Heilbronn Gmbh Klinik Fur Radiologie, Minimalinvasive Therapien Und Nuklearmedizin, Heilbronn, Not set
Universitares Krebszentrum Leipzig, Leipzig, Not set
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola, Not set
Istituto Europeo Di Oncologia, Milano, Not set
Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Not set
Iov Istituto Oncologico Veneto Irccs, Padova, Not set
Azienda Ospedaliera Universitaria Delle Marche, Torrette, Not set
Akita University Hospital, Akitashi, Akita
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Kyushu Medical Center, Fukuokacity, Fukuoka
Nho Kyushu Cancer Center, FukuokaShi, Fukuoka
Hyogo Cancer Center, AkashiShi, Hyogo
Johas Kansai Rosai Hospital, Amagasakishi, Hyogo
Kanagawa Cancer Center, Yokohamashi, Kanagawa
University Hospital, Kyoto Prefectural Univ of Medicine, KyotoShi, Kyoto
Osaka International Cancer Institute, OsakaShi, Osaka
The University of Osaka Hospital, Suitashi, Osaka
Saitama Cancer Center, Kitaadachigun, Saitama
National Cancer Center Hospital, ChuoKu, Tokyo
Hiroshima University Hospital, Hiroshima, Not set
Kumamoto University Hospital, Kumamoto, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Keimyung University Dongsan Hospital, Dalseogu, Daegu Gwang'yeogsi
Cha Bundang Medical Center, Cha University, BundangGu SeongnamSi, Gyeonggi-do
Seoul National University Bundang Hospital, BundangGu SeongnamSi, Gyeonggi-do
Gachon University Gil Medical Center, NamdongGu, Incheon Gwang'yeogsi
Chonnam National University Hwasun Hospital, HwasunGun, Jeollanam-do
Smg Snu Boramae Medical Center, DongjakGu, Seoul Teugbyeolsi
Korea University Guro Hospital, GuroGu, Seoul Teugbyeolsi
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi
Samsung Medical Center Hematology Oncology, Seoul, Seoul Teugbyeolsi
Asan Medical Center, SongpaGu, Seoul Teugbyeolsi
Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozow, Not set
Szpital Wojewodzki Im Mikoaja Kopernika W Koszalinie, Koszalin, Not set
Spzoz Mswia Z Warminsko Mazurskim Centrum Onkologii, Olsztyn, Not set
Narodowy Instytut Onkologii Im Marii Skodowskiej Curie Pastwowy Instytut Badawczy, Warszawa, Not set
Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca, Not set
Medisprof Cancer Center, ClujNapoca, Not set
Radiotherapy Center Cluj, ClujNapoca, Not set
Sc Centrul de Oncologie Sf Nectarie Srl, Craiova, Not set
Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk, Arkhangel'skaya Oblast'
Rbih Ivanovo Regional Oncological Dispensary, Ivanovo, Ivanovskaya Oblast'
State Budget Healthcare Institution Leningrad Regional Clinical Oncologic Dispensary, Kuzmolovsky, Leningradskaya Oblast'
Orenburg Regional Clinical Oncology Center, Orenburg, Orenburgskaya Oblast'
Rostov State Medical University, RostovonDon, Rostovskaya Oblast'
Pavlov First Saint Petersburg State Medical University, SaintPetersburg, Sankt-Peterburg
Fsbi National Medical Research Center For Oncology Na Nn Petrov of the Moh of the Rf, SaintPetersburg, Not set
Hospital Universitario Vall Dhebron, Barcelona, Not set
Institut Catala Doncologia, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Hospital Regional Universitario de Malaga, Malaga, Not set
Hospital Universitario Central de Asturias, Oviedo, Not set
Hospital Universitario Miguel Servet, Zaragoza, Not set
Chiayi Chang Gung Memorial Hospital, Chiayi, Not set
Chi Mei Hospital Liouying, Liuying Dist, Not set
China Medical University Hospital, North Dist, Not set
Chi Mei Medical Center, Yongkang Dist, Not set
The Christie Hospital, Greater Manchester, Not set
Guys and St Thomas Hospital Nhs Foundation Trust, London, Not set
Conditions: Esophageal Squamous Cell Carcinoma (ESCC)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Recruiting
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Research Site, Tucson, Arizona +290 locations
Research Site, Tucson, Arizona
Research Site, Springdale, Arkansas
Research Site, Beverly Hills, California
Research Site, Glendale, California
Research Site, Los Alamitos, California
Research Site, Redlands, California
Research Site, San Francisco, California
Research Site, Walnut Creek, California
Research Site, West Haven, Connecticut
Research Site, Newark, Delaware
Research Site, Bay Pines, Florida
Research Site, Fort Lauderdale, Florida
Research Site, Gainesville, Florida
Research Site, Gainesville, Florida
Research Site, Jacksonville, Florida
Research Site, Athens, Georgia
Research Site, Atlanta, Georgia
Research Site, Boise, Idaho
Research Site, Chicago, Illinois
Research Site, Decatur, Illinois
Research Site, Hinsdale, Illinois
Research Site, Quincy, Illinois
Research Site, Waterloo, Iowa
Research Site, Lexington, Kentucky
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Louisville, Kentucky
Research Site, Alexandria, Louisiana
Research Site, Baton Rouge, Louisiana
Research Site, Covington, Louisiana
Research Site, Shreveport, Louisiana
Research Site, Shreveport, Louisiana
Research Site, South Portland, Maine
Research Site, Baltimore, Maryland
Research Site, Bethesda, Maryland
Research Site, Detroit, Michigan
Research Site, Grand Rapids, Michigan
Research Site, Duluth, Minnesota
Research Site, Rochester, Minnesota
Research Site, Bridgeton, Missouri
Research Site, Columbia, Missouri
Research Site, Kansas City, Missouri
Research Site, Lincoln, Nebraska
Research Site, Camden, New Jersey
Research Site, Buffalo, New York
Research Site, East Syracuse, New York
Research Site, Westbury, New York
Research Site, Cincinnati, Ohio
Research Site, Bend, Oregon
Research Site, Medford, Oregon
Research Site, Salem, Oregon
Research Site, Hershey, Pennsylvania
Research Site, York, Pennsylvania
Research Site, Sioux Falls, South Dakota
Research Site, Chattanooga, Tennessee
Research Site, Nashville, Tennessee
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Kingwood, Texas
Research Site, Lubbock, Texas
Research Site, Round Rock, Texas
Research Site, Fairfax, Virginia
Research Site, Fredericksburg, Virginia
Research Site, Olympia, Washington
Research Site, Seattle, Washington
Research Site, Silverdale, Washington
Research Site, Spokane, Washington
Research Site, Tacoma, Washington
Research Site, Wenatchee, Washington
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, La Plata, Not set
Research Site, Pilar, Not set
Research Site, Rosario, Not set
Research Site, Darlinghurst, Not set
Research Site, Hyde Park, Not set
Research Site, Southport, Not set
Research Site, Wollongong, Not set
Research Site, Innsbruck, Not set
Research Site, Krems, Not set
Research Site, Rankweil, Not set
Research Site, Wien, Not set
Research Site, Wien, Not set
Research Site, Anderlecht, Not set
Research Site, Brussels, Not set
Research Site, Charleroi, Not set
Research Site, Kortrijk, Not set
Research Site, Ottignies, Not set
Research Site, Sint-Niklaas, Not set
Research Site, Barretos, Not set
Research Site, Florianópolis, Not set
Research Site, Ijuí, Not set
Research Site, Londrina, Not set
Research Site, Porto Alegre, Not set
Research Site, Salvador, Not set
Research Site, Sao Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Taubaté, Not set
Research Site, Saint John, New Brunswick
Research Site, Sydney, Nova Scotia
Research Site, Hamilton, Ontario
Research Site, Sault Ste. Marie, Ontario
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changchun, Not set
Research Site, Changde, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Dalian, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Harbin, Not set
Research Site, Hefei, Not set
Research Site, Hefei, Not set
Research Site, Jinan, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Linyi, Not set
Research Site, Nanchang, Not set
Research Site, Ningbo, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Taiyuan, Not set
Research Site, Tianjin, Not set
Research Site, Wenzhou, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Yangzhou, Not set
Research Site, Yueyang, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Avignon, Not set
Research Site, La Rochelle Cedex, Not set
Research Site, Lyon, Not set
Research Site, Nimes, Not set
Research Site, Rennes, Not set
Research Site, Strasbourg Cedex, Not set
Research Site, Suresnes, Not set
Research Site, Toulon Cedex 9, Not set
Research Site, Bad Berka, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Esslingen, Not set
Research Site, Frankfurt, Not set
Research Site, Gauting, Not set
Research Site, Gießen, Not set
Research Site, Großhansdorf, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Hannover, Not set
Research Site, Heidelberg, Not set
Research Site, Hemer, Not set
Research Site, Homburg, Not set
Research Site, Kassel, Not set
Research Site, Kiel, Not set
Research Site, Krefeld, Not set
Research Site, Köln, Not set
Research Site, Minden, Not set
Research Site, Moers, Not set
Research Site, München, Not set
Research Site, Regensburg, Not set
Research Site, Würzburg, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Gyöngyös, Not set
Research Site, Győr, Not set
Research Site, Pécs, Not set
Research Site, Székesfehérvár, Not set
Research Site, Törökbálint, Not set
Research Site, Calicut, Not set
Research Site, Delhi, Not set
Research Site, Kolkata, Not set
Research Site, Madurai, Not set
Research Site, Mumbai, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, Pondicherry, Not set
Research Site, Surat, Not set
Research Site, Varanasi, Not set
Research Site, Firenze, Not set
Research Site, Monza, Not set
Research Site, Orbassano, Not set
Research Site, Padova, Not set
Research Site, Peschiera Del Garda, Not set
Research Site, Roma, Not set
Research Site, Amagasaki-shi, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kawagoe-shi, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Matsusaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama, Not set
Research Site, Ota-shi, Not set
Research Site, Saitama-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Cheongju-si, Not set
Research Site, Incheon, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Suwon-si, Not set
Research Site, George Town, Not set
Research Site, Johor Bahru, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Alkmaar, Not set
Research Site, Ede, Not set
Research Site, Groningen, Not set
Research Site, Leidschendam, Not set
Research Site, Veldhoven, Not set
Research Site, Zwolle, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Biała Podlaska, Not set
Research Site, Białystok, Not set
Research Site, Bydgoszcz, Not set
Research Site, Bystra, Not set
Research Site, Poznań, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, San Juan, Not set
Research Site, San Juan, Not set
Research Site, Barcelona, Not set
Research Site, Las Palmas de Gran Canaria, Not set
Research Site, Lérida, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Sevilla, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Dusit, Not set
Research Site, Nakhon Ratchasima, Not set
Research Site, Songkla, Not set
Research Site, Antalya, Not set
Research Site, İstanbul, Not set
Research Site, Yenimahalle, Not set
Research Site, Aberdeen, Not set
Research Site, Cambridge, Not set
Research Site, Edinburgh, Not set
Research Site, Exeter, Not set
Research Site, Greater London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Manchester, Not set
Research Site, Newcastle upon Tyne, Not set
Research Site, Preston, Not set
Research Site, Can Tho, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh City, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Vinh, Not set
Conditions: Non-small Cell Lung Cancer
25 - 36 of 293